Allergen-specific immunotherapy in the treatment of IgE-mediated allergy has been used for longer than a century; yet, its major form, subcutaneous immunotherapy (SCIT) has not become a widely accepted routine treatment for allergy. The gene discussed is IGHE; the disease is Allergy.